Project Details
| Status | Active |
|---|---|
| Effective start/end date | 2/10/21 → 2/9/26 |
Funding
- Pfizer, Inc.: $11,684.62
(Pfizer Pregnant COVID Vaccine C4591015) A PHASE 2/3, PLACEBO CONTROLLED, RANDOMIZED, OBSERVER BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS COV 2 RNA VACCINE CANDIDATE (BNT162b2) AGAINST COVID 19 IN HEALTHY PREGNANT WOME
- Saade, George (PI)
Project: Other project